Acompanhe as Notícias da Recifes

Researchers at the USC Viterbi School of Engineering and Keck School of Medicine of USC have engineered a genetic tool that addresses one of the most persistent obstacles in cancer immunotherapy: the physical softness of tumors.

Cancer occurs when cells divide uncontrollably and displace healthy cells.

Anti-Müllerian hormone (AMH) appears to predict the benefit of chemotherapy plus endocrine therapy (CET) versus ET alone in premenopausal women younger than 55 years with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer with a recurrence s

Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment outcome in an adolescent with an advanced, treatment-resistant kidney tumor.

A large population-based study led by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Mass General Brigham suggests that genetic testing added to routine newborn screening could identify some babies at increased risk of developing cancer before

A cancerous tumor is not a single enemy.

Bella Ramsey leads this likable coming-of-age story where the shared experience of adolescent cancer gives new warmth to a familiar genreBella Ramsey leads the cast of this likable coming-of-age movie from 25-year-old actor-turned-director George Jaques about a summer camp for te

Researchers at the University of Wisconsin–Madison have developed a simpler way to produce a fast-growing class of targeted cancer therapies, a discovery that could make the medicines easier to manufacture consistently while driving the development of new treatment options.

Ultra-processed foods (UPFs) account for nearly 60% of adults' and 70% of children's energy intake in the United States. Destaque: 60%, 70%.

A new study led by researchers at The University of Texas MD Anderson Cancer Center has shown that inflammatory arthritis occurring as a side effect of immune checkpoint inhibitors behaves like an immune-memory disease, suggesting that certain immune cell populations could serve

UCLA researchers have created a blood test that can scan DNA signals for multiple cancers, liver diseases, and signs of organ damage—and even indicate where trouble may be developing.

The first nationwide study comparing urban and rural rates of receiving radiotherapy treatment for three major cancers highlighted significant geographic and equity differences.